Here's the latest wisdom from the wanna-be analyst who spends most of his time these days responding to his own posts LMAO. Copied here to generate some much needed laughter. Watch his predictions change as the story unfolds, while he will continue to claim he was dead on with most of them. LMAO Truly a legend in his own mind.

Quote:

---

The stock is currently valued at about the right level. It is VERY likely that development of MANF will NOT lead to that much shareholder value because AMBS does not have any money, or currency. Lympro did not pan out. Eltoprazine has no funding and no Principal investigator. MJFF wants more data on Eltoprazine before pulling the trigger.

---

Ollie commented, "He's never going to make it as a biotech analyst as long as his anal sphincter muscle is squeezing his neck and cutting off oxygen flow to his brain."


                                    – The IRRELEPHANT –
           Posting Irrelevant Nonsense on a Message Board Near You